# The Efficacy in Treatment of Facial Melasma Combined With Thulium 1927-nm Fractional Laser and Topical H2R Antagonist

> **NCT06313307** · NA · COMPLETED · sponsor: **Second Affiliated Hospital of Xi'an Jiaotong University** · enrollment: 16 (actual)

## Conditions studied

- Melasma

## Interventions

- **COMBINATION_PRODUCT:** topical H2R antagonist
- **DEVICE:** Thulium 1927-nm Fractional Laser

## Key facts

- **NCT ID:** NCT06313307
- **Lead sponsor:** Second Affiliated Hospital of Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2023-11-25
- **Final completion:** 2023-11-25
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06313307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06313307, "The Efficacy in Treatment of Facial Melasma Combined With Thulium 1927-nm Fractional Laser and Topical H2R Antagonist". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06313307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*